Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways

Circulation. 2003 May 27;107(20):2583-8. doi: 10.1161/01.CIR.0000068339.04731.4D. Epub 2003 May 12.

Abstract

Background: The aim of this study was to test the electrophysiological effects of continuous enhanced vagal tone on dual atrioventricular (AV) nodal and accessory pathways.

Methods and results: This study included 10 patients with typical, slow-fast AV nodal reentrant tachycardia (AVNRT) and 10 patients with AV reciprocating tachycardia. Electrophysiological data were measured before and during continuous vagal enhancement by using phenylephrine infusion (0.6 to 1.5 microg/kg per min). For patients with AVNRT, during phenylephrine infusion, 1:1 conduction times over the anterograde fast and slow and retrograde fast pathways were prolonged (453+/-64 to 662+/-120 ms, P<0.001; 379+/-53 to 443+/-95 ms, P<0.05; 405+/-112 to 442+/-118 ms, P<0.05). The effective refractory period and functional refractory period of the anterograde fast pathway were prolonged with phenylephrine (394+/-73 to 544+/-128 ms, P<0.001; 454+/-60 to 596+/-118 ms, P<0.001). In contrast, the effective refractory period and functional refractory period of the anterograde slow and retrograde fast were not significantly changed. No significant change was observed in the conduction or refractoriness of the accessory pathways in patients with AV reciprocating tachycardia nor in atrial or ventricular refractoriness.

Conclusions: Enhanced vagal tone produces disparate effects on the refractoriness of the slow and fast AV nodal conduction pathways, with the anterograde fast pathway being the most sensitive. These changes are conducive to induction of AVNRT with a premature atrial complex and may explain in part the relatively common occurrence of AVNRT during sleep or other periods of presumed increased parasympathetic tone.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Atrioventricular Node / drug effects
  • Atrioventricular Node / physiopathology*
  • Cardiac Pacing, Artificial
  • Catheter Ablation
  • Electrocardiography / drug effects
  • Electrophysiologic Techniques, Cardiac
  • Heart Conduction System / drug effects
  • Heart Conduction System / physiopathology*
  • Humans
  • Middle Aged
  • Parasympathetic Nervous System / drug effects
  • Parasympathetic Nervous System / physiopathology
  • Phenylephrine / pharmacology
  • Tachycardia, Atrioventricular Nodal Reentry / drug therapy
  • Tachycardia, Atrioventricular Nodal Reentry / physiopathology
  • Tachycardia, Atrioventricular Nodal Reentry / surgery
  • Tachycardia, Supraventricular / drug therapy
  • Tachycardia, Supraventricular / physiopathology*
  • Tachycardia, Supraventricular / surgery
  • Time Factors
  • Vagus Nerve / drug effects
  • Vagus Nerve / physiopathology*

Substances

  • Phenylephrine